Minimal change disease caused by exposure to mercury-containing skin lightening cream: a report of 4 cases

Clin Nephrol. 2013 Apr;79(4):326-9.

Abstract

Mercury is a known cause of nephrotic syndrome and the underlying renal pathology in most of the reported cases was membranous nephropathy. We describe here 4 cases of minimal change disease following exposure to mercury-containing skin lightening cream for 2 - 6 months. The mercury content of the facial creams was very high (7,420 - 30,000 parts per million). All patients were female and presented with nephrotic syndrome and heavy proteinuria (8.35 - 20.69 g/d). The blood and urine mercury levels were 26 - 129 nmol/l and 316 - 2,521 nmol/d, respectively. Renal biopsy revealed minimal change disease (MCD) in all patients. The use of cosmetic cream was stopped and chelation therapy with D-penicillamine was given. Two patients were also given steroids. The time for blood mercury level to normalize was 1 - 7 months, whereas it took longer for urine mercury level to normalize (9 - 16 months). All patients had complete remission of proteinuria and the time to normalization of proteinuria was 1 - 9 months. Mercury-containing skin lightening cream is hazardous because skin absorption of mercury can cause minimal change disease. The public should be warned of the danger of using such products. In patients presenting with nephrotic syndrome, a detailed history should be taken, including the use of skin lightening cream. With regard to renal pathology, apart from membranous nephropathy, minimal change disease should be included as another pathological entity caused by mercury exposure or intoxication.

Publication types

  • Case Reports

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Biopsy
  • Chelating Agents / therapeutic use
  • Female
  • Humans
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology
  • Mercury Compounds / administration & dosage
  • Mercury Compounds / adverse effects*
  • Mercury Compounds / blood
  • Mercury Compounds / urine
  • Middle Aged
  • Nephrosis, Lipoid / chemically induced*
  • Nephrosis, Lipoid / diagnosis
  • Nephrosis, Lipoid / drug therapy
  • Nephrosis, Lipoid / metabolism
  • Penicillamine / therapeutic use
  • Proteinuria / chemically induced
  • Skin Absorption
  • Skin Cream
  • Skin Lightening Preparations / administration & dosage
  • Skin Lightening Preparations / adverse effects*
  • Skin Lightening Preparations / metabolism
  • Skin Pigmentation / drug effects*
  • Steroids / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Chelating Agents
  • Mercury Compounds
  • Skin Lightening Preparations
  • Steroids
  • Penicillamine